<DOC>
	<DOCNO>NCT00472901</DOCNO>
	<brief_summary>The purpose study determine whether afamelanotide ( CUV1647 ) formulation effective prevent PLE episode reduce severity PLE symptoms patient well documented history disease . The study also aim determine whether treatment afamelanotide ( CUV1647 ) reduce use rescue medication group .</brief_summary>
	<brief_title>Phase III Trial CUV1647 Polymorphic Light Eruption ( PLE )</brief_title>
	<detailed_description>Polymorphic Light Eruption ( PLE ) prevalent photosensitivity disorder , occur 20 % European US population 5 % Australian population . The disease characterise rash intensely itchy blister , bump patch present area skin expose sun . There lack effective treatment available condition common available form therapy include sun avoidance use use steroid and/or phototherapy .</detailed_description>
	<mesh_term>Exanthema</mesh_term>
	<mesh_term>Dermatitis , Contact</mesh_term>
	<mesh_term>alpha-MSH</mesh_term>
	<criteria>Aged 18 70 year inclusion . Well documented history moderate/severe PLE diagnosed/confirmed photodermatologist photobiologist . Newly diagnose patient moderate/severe PLE include number establish patient limit provided diagnosis confirm photodermatologist photobiologist . Recurrent episodes occur least year , develop country ( exclude patient affect travel sunny climate ) . Have give write informed consent participate study . Personal history melanoma , lentigo maligna multiple ( 3 ) dysplastic nevus . Current Bowen 's Disease , basal cell carcinoma , squamous cell carcinoma malignant skin lesion . Documented history photosensitive condition . Female pregnant ( confirm positive serum Î²HCG pregnancy test prior baseline ) lactating . Females childbearing potential use adequate contraceptive measure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Polymorphic Light Eruption ( PLE )</keyword>
	<keyword>Afamelanotide</keyword>
	<keyword>CUV1647</keyword>
	<keyword>photoprotection</keyword>
	<keyword>sun poisoning</keyword>
</DOC>